AI Article Synopsis

  • Dendritic cells (DCs) utilize different uptake mechanisms, like macropinocytosis and phagocytosis, to present antigens (Ags) to T cells, with Ag sampling being crucial for DC biology.
  • The glucocorticoid-induced leucine zipper protein (GILZ) selectively inhibits macropinocytosis in immature and recently activated DCs, particularly in the CD8α DC subset, while not affecting other uptake methods.
  • Although GILZ's modulation of Ag uptake influences cross-presentation to CD8 T cells, it does not change Ag presentation efficiency to CD4 T cells.

Article Abstract

Ag sampling is a key process in dendritic cell (DC) biology. DCs use constitutive macropinocytosis, receptor-mediated endocytosis, and phagocytosis to capture exogenous Ags for presentation to T cells. We investigated the mechanisms that regulate Ag uptake by DCs in the steady-state and after a short-term LPS exposure in vitro and in vivo. We show that the glucocorticoid-induced leucine zipper protein (GILZ), already known to regulate effector versus regulatory T cell activation by DCs, selectively limits macropinocytosis, but not receptor-mediated phagocytosis, in immature and recently activated DCs. In vivo, the GILZ-mediated inhibition of Ag uptake is restricted to the CD8α DC subset, which expresses the highest GILZ level among splenic DC subsets. In recently activated DCs, we further establish that GILZ limits p38 MAPK phosphorylation, providing a possible mechanism for GILZ-mediated macropinocytosis control. Finally, our results demonstrate that the modulation of Ag uptake by GILZ does not result in altered Ag presentation to CD4 T cells but impacts the efficiency of cross-presentation to CD8 T cells. Altogether, our results identify GILZ as an endogenous inhibitor of macropinocytosis in DCs, the action of which contributes to the fine-tuning of Ag cross-presentation.

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1600561DOI Listing

Publication Analysis

Top Keywords

glucocorticoid-induced leucine
8
leucine zipper
8
zipper protein
8
macropinocytosis receptor-mediated
8
activated dcs
8
dcs
6
macropinocytosis
5
gilz
5
protein controls
4
controls macropinocytosis
4

Similar Publications

Background And Aims: Given the role of Receptor for Activated C Kinase 1 (RACK1) in both immune cell activation and in the maintenance of the intestinal epithelial barrier integrity, we investigated whether it was involved in inflammatory bowel disease (IBD).

Methods: RACK1 expression was analyzed in intestinal mucosal samples of healthy and IBD patients, in mice with chemically induced colitis, and in diseased in vitro 2D and 3D coculture models by luciferase assay, reverse transcription-quantitative PCR, Western blotting, immunofluorescence, and immunohistochemistry. Based on our finding that glucocorticoid-induced leucine zipper (GILZ or tsc22d3) positively correlates with RACK1 expression in IBD patients, GILZ knockout mice and cell silencing experiments were performed.

View Article and Find Full Text PDF

Purpose: Within human skeletal muscle, statin treatment leads to elevated levels of the glucocorticoid-induced leucine zipper (GILZ). Further, GILZ mediates the muscle-related side effects of statins. Physical exercise leads to GILZ suppression, in a mechanosensitive manner.

View Article and Find Full Text PDF

Inflammatory bowel diseases (IBD) have a complex, poorly understood pathogenesis and lack long-lasting effective treatments. Recent research suggests that intestinal fungal dysbiosis may play a role in IBD development. This study investigates the effects of the glucocorticoid-induced leucine zipper protein (GILZp)", known for its protective role in gut mucosa, and a yeast extract (Py) with prebiotic properties, either alone or combined, in DSS-induced colitis.

View Article and Find Full Text PDF

Glucocorticoid receptor response and glucocorticoid-induced leucine zipper expression in neutrophils of critically ill patients with traumatic and non-traumatic brain injury.

Front Endocrinol (Lausanne)

September 2024

First Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece.

Objective: Critically ill patients, including those with brain injuries (BI), are frequently hospitalized in an intensive care unit (ICU). As with other critical states, an adequate stress response is essential for survival. Research on the hypothalamic-pituitary-adrenal gland (HPA) axis function in BI has primarily focused on assessing ACTH and cortisol levels.

View Article and Find Full Text PDF

Deacetylation by SIRT6 increases the stability of GILZ to suppress NSCLC cell migration and invasion.

Cell Signal

December 2024

School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, PR China. Electronic address:

Article Synopsis
  • GILZ is a protein that helps control how cancer cells spread (metastasis) in certain types of cancer, especially non-small cell lung cancer (NSCLC).
  • In this study, scientists found that while GILZ doesn't stop cancer cells from growing, it does stop them from spreading to other parts of the body.
  • Another protein called SIRT6 helps keep GILZ stable so it can work better against cancer cell movement, making GILZ a potential target for new cancer treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!